Inoculation of golden Syrian hamsters with Venezuelan encephalitis (VE) virus results in a sustained diminution in glucosestimulated insulin release that is correctable by cyclic (c) AMP analogs and phosphodiesterase inhibitors. This suggested the importance of directly measuring cAMP content in VE-infected and control islets in response to insulin secretagogues. The basal cAMP content of YE-infected islets (0.14±0.02 pmol/pg islet DNA) was approximately half that of control islets (0.27±0.02 pmol/flg islet DNA) (P < 0.05). In the presence of 10 pM glucagon (and 3 mM glucose), the rate of cAMP generation in VEinfected islets was only half that of control islets. With 10 mM a-ketoisocaproic acid, the rates of cAMP generation were indistinguishable between control and experimental groups. In response to 20 mM glucose and 3-isobutyl-1-methylxanthine (IBMX) (a phosphodiesterase inhibitor), cAMP generation in VE-infected islets was 81% (NS) of the control rate. When a more specific phosphodiesterase inhibitor, RO 20-1724, was used with 20 mM glucose, cAMP generation in the infected islets was only 44% (P < 0.001) of the control value. Insulin secretion over the perifusion period paralleled the cAMP levels. In the presence of 10 mM a-ketoisocaproic acid, there was no difference in insulin secretion between VE-infected and control islets, while there was a statistically significant (P < 0.05) difference with 10 pM glucagon or 20 mM glucose (in 1 mM RO 20-1724). These data point to a defect in the cAMP generation system of VE-infected islets, although additional factors involved in insulin secretion may also be impaired by the virus.
Introduction
A possible role ofviruses in the pathogenesis ofdiabetes mellitus has been proposed since the mid-nineteenth century (1) (2) (3) . Most ofthe studies performed in animal models ofviral diabetes have used viruses highly lytic to beta cells in vivo, in which islet destruction parallels the degree of hyperglycemia (4, 5 1. Abbreviations used in this paper: B, rate of cyclic AMP generation; cAMP, cyclic AMP; IBMX, 3-isobutyl-1-methylxanthine; RO 20-1724, d-4-(3-butoxy-4-methoxybenzyl)-2-imidazol-idinone; VE, Venezuelan encephalitis virus; VEsm, TC-83 vaccine strain of VE. in glucose-stimulated insulin release, in vivo (6) and in vitro in isolated, perifused pancreatic islets of Langerhans (7) . After VE infection, no long-term morphologic alterations in the pancreas are observed (6, 7) . Specifically, there were no changes in islet volume density, volume density ofindividual islet subtypes (beta, alpha, delta, pancreatic polypeptide), or beta cell granulation in virus infected islets (7) . Decreased insulin release can be corrected in vitro by 8-bromo-cyclic AMP (cAMP), dibutyryl cAMP, and by the phosphodiesterase inhibitor, theophylline (7) . a-Ketoisocaproic acid, an insulin secretagogue whose action is independent of glucose, induces normal insulin release in VE-infected islets (8) . The finding that cAMP analogs and phosphodiesterase inhibitors can correct the virus-mediated diminution in insulin secretion suggested the importance of measuring the cAMP content in VE-infected and control islets in response to insulin secretagogues.
Methods
Animals and virus preparation. The LVG strain of golden Syrian hamsters (Charles River Breeding Laboratories, Wilmington, MA) weighing between I 10 and 130 g, were used in these studies. The animals were fed with hamster chow and water ad libidum until the time ofstudy. Hamsters were inoculated with either I X 101 plaque-forming units of a plaquepurified variant of the TC-83 vaccine strain of VE (VEsro) virus in 0.2 ml ofHanks' balanced salt solution (Gibco, Grand Island, NY) adjusted to pH 7.4, or sham-inoculated with 0.2 ml i.p. of diluent. VEmm was assayed by counting plaque-forming units on chicken embryonic cell monolayers under agar (9) . Preinoculation and 21-d postinoculation acetone-extracted sera were measured for the presence of antiviral antibody by a microtiter hemagglutination-inhibition test (10) and only hamsters converting from negative titers to titers of >40 were used in the studies. Glucose tolerance tests were performed with measurement ofglucose and insulin levels preinoculation and 23 d after administration of virus as described previously (6 In the perifusion protocols, the a-ketoisocaproic acid was obtained from Sigma Chemical Co., and the glucagon was obtained from Dr. Mary Root, Eli Lilly and Co. Since the action of a-ketoisocaproic acid is independent of glucose, a 15-min period of perifusion with glucosefree medium preceded all additions of a-ketoisocaproic acid.
Islet DNA analysis. DNA content of the 25 islets in each chamber was determined by a very sensitive fluorimetric method using diaminobenzoic acid (Aldrich Chemical Co., Inc., Milwaukee, WI) (15) . Insulin and other proteins were extracted first with acid-ethanol, and then the insoluble material was further purified using ethanol and ether before DNA assay. All insulin and cAMP levels were corrected for DNA content to adjust for any differences in size between control and VE-infected islets. cAMP assay. The cAMP was extracted from the islets by a 16-h incubation with 15% (wt/wt) TCA at 40C. The TCA was removed by water-saturated ether extraction. Samples were lyophilized and cAMP content was measured by a sensitive double antibody radioimmunoassay modified from that ofZawalich et al. (16). Purified cAMP (Sigma Chemical Co.) was used as standard. The anti-acetyl cAMP antibody (prepared in rabbits) was purchased from New England Nuclear, Boston, MA. 2sI-cAMP was obtained from Dr. George Vanderhoff, University ofVirginia School of Medicine, and the second antibody (goat anti-rabbit IgG) was obtained from Arnel Co, Brooklyn, NY. cAMP standards and samples were acetylated to yield 2'-O-acetyl cAMP in order to increase the sensitivity of the assay to the femtomole range ( 17) . Analysis ofdata. The rate ofcAMP generation (B) and the regression lines were calculated by the method of least squares ( 17) . This rate represents the net effect of production and degradation of cAMP, which reflects a multiplicity of factors. Differences between mean total insulin secretion ofcontrol and VE-infected islets were analyzed for significance using Student's t test for unpaired variates. The variance of the insulin data is expressed as SEM. Correlation coefficients were calculated (18) .
Results
Glucose tolerance tests. 23 d after inoculation with VEsTm virus, all hamsters were glucose-intolerant (mean 60 min glucose = 460±10 mg/dl infected vs. mean 60 min glucose = 350±8 mg/dl control, P < 0.01). VEsXm virus-infected hamsters displayed decreased insulin levels after intraperitoneal glucose injection (mean 60 min insulin = 40±4 ,U/ml infected vs. mean 60 min insulin = 138±7 ,uU/ml control, P < 0.01).
Effect ofglucose on islet cAMP generation. In the absence ofa phosphodiesterase inhibitor, control (uninfected) islet cAMP content at time 0 with 3 mM glucose was 0.30±0.02 pmol/,ig islet DNA, whereas VE-infected islet cAMP content was 0.16±0.02 pmol/,g islet DNA. This difference was statistically significant (P < 0.05). In the presence of each secretagogue, cAMP was undetectable in the perifusion buffer at all times.
Effect ofa-ketoisocaproic acid and IBMX on cAMP generation. a-Ketoisocaproic acid (which cannot be metabolized to glucose) induces the same insulin release in perifuLsed hamster control and VEW virus-infected islets (8) . a-Ketoisocaproic acid also increases the cAMP content of isolated rat islets (19) .
Under basal conditions (3 mM glucose in the perifusion buffer), the mean cAMP content of VEsT1 virus-infected islets (23) . Basal cAMP content (with 3 mM glucose and 1 mM IBMX) is lower in VESTD virus infected than in control islets (P < 0.05) (Fig. 2) . In response to 10 ,M glucagon, cAMP content is lower after 10, 20, and 40 min in the infected islets (P < 0.05). cAMP increased 8.5-fold in control islets, but only 5.7-fold in VE-infected islets after 20 min (P < 0.001). The rate of cAMP generation (0.0329 pmol cAMP/,ug islet DNA per minute) in VESTD infected islets is half that of control islets (B = 0.0664 pmol cAMP/,ug islet DNA per minute) (P < 0.001) during a 40-min perifusion.
Effect ofglucose and IBMX on cAMP generation. Based upon observations with isolated, perifused islets (7), we hypothesized that cAMP generation in VEsT-infected islets would be impaired in response to 20 mM (high) glucose. In the presence of 20 mM glucose (and 1 mM IBMX), the rate of cAMP generation in VEinfected islets was 81% (NS) that in control islets (Fig. 3) . This may be due to masking ofthe glucose-mediated increase in cAMP content by activation of the adenosine receptor. In addition to suppressing phosphodiesterase, IBMX is an adenosine (Al) receptor antagonist (24) , and can thus alter cAMP generation in islets (25) .
Effect ofglucose and RO 20-1724 on cAMP generation. Experiments were conducted with the phosphodiesterase inhibitor, 0.93t (5) 0.63* (10) 0.80t (9) VE and RO 20-1724 on total insulin secretion from VEsTD-infected and control hamsters. cAMP may serve as a second messenger for insulin release. Therefore, insulin secretion in VE-infected islets was correlated with cAMP production. Insulin and cAMP levels closely correlate (P < 0.05) in control and VE-infected islets as well as when the two are combined before analysis (Table  I) . There is no difference in response to 10 mM a-ketoisocaproic acid or 20 mM glucose (and 1 mM IBMX) in insulin secretion between control and VE-infected islets (paralleling the absence of a difference in cAMP content) (Figs. 1, 3 , and 5). In contrast, in the presence of 10 ,uM glucagon and 3 mM glucose (and I mM IBMX), there is a significant (P < 0.05) difference between mean total insulin secretion for control and VE-infected islets. Mean total insulin secretion in control and VE-infected islets was also different (P < 0.05) with 20 mM glucose and 1 mM RO 20-1724 (Fig. 5) . cAMP generation and insulin secretion are closely linked with these secretagogues. The finding that absolute levels of cAMP do not always predict the corresponding insulin levels suggests that factors other than the cAMP generating system of the beta cell are modified by viral infection. Such factors could include calmodulin and calcium-sensitive enzymes (27) .
Discussion
Viral agents, autoimmunity, chemicals, and toxins may contribute singly or in combination to the pathogenesis of diabetes mellitus (28-30). We developed a hamster model in which VE virus infection results in a significant diminution of glucosestimulated insulin release in vivo and vitro (6, 7) . Since VE virus is relatively non-lytic, no long-term morphologic nor morphometric changes are demonstrable in the islets from infected hamsters (6, 7) . The decrease in insulin release triggered by glucose can be corrected in vitro in isolated perifused islets treated with agents that raise cAMP levels: theophylline (a phosphodiesterase inhibitor) and cAMP analogs (7).
The virus-induced defect in insulin release does not result from a nonspecific membrane effect. Thus, when VE-infected and control islets are perifused with a-ketoisocaproic acid in the absence of glucose, no difference is observed in insulin release in the two groups (8) . a-Ketoisocaproic acid, a metabolite of leucine that is ketogenic, stimulates insulin secretion in vivo and in vitro, and islet cAMP content (8, 19, 31) . The decrease in insulin secretion is also correctable with tolbutamide (7), and resembles the clinical picture found in noninsulin-dependent diabetes mellitus (30). In the present study, changes of intracellular cAMP content of islets were measured over time in response to insulin secretagogues to assess the locus at which VE virus interacts with the adenylate cyclase system of the beta cell. In the presence of 10 ,M glucagon (which depends on glucose for its ability to stimulate insulin release), the rate of generation of cAMP in islets from VE-infected hamsters is half that of control islets (Fig. 2) (P < 0.001). In islets exposed to a-ketoisocaproic acid (which acts independently of glucose to induce insulin release), the rates in control and virus infected groups are indistinguishable (Fig.  1 A) . cAMP is rapidly degraded in cells to 5' AMP by one or more phosphodiesterases (13, 32) . This necessitated the use of a phosphodiesterase inhibitor in the perifusion system to obtain meaningful values ofislet cAMP content. However, IBMX affects the adenosine receptor, which modulates adenylate cyclase activity (25) . With IBMX, there was no difference in the rate of generation of cAMP in control and VE-infected islets in the presence of20 mM glucose. However, when RO 20-1724, which does not affect the adenosine receptor (26) , was used, the generation of cAMP in VE-infected islets was 44% of the control value (Fig. 4) . These results could be explained if IBMX were more inhibitory to phosphodiesterase and VE-infected islets had a greater concentration of phosphodiesterase.
Although there is a significant difference (P < 0.05) in basal cAMP levels in control and VE islets (Figs. 1-4) , the importance of this difference is not established. a-Ketoisocaproic acid stimulated cAMP generation in VE-infected islets overcomes the decreased basal levels in contrast to glucose and glucagon, which exaggerate the diminution in cAMP production. This difference in basal cAMP content is glucose-dependent since the basal medium contains 3 mM glucose.
Many agents that stimulate insulin release, such as glucose (33) , glucagon (21, 22) , tolbutamide (33) , and a-ketoisocaproic acid (i9), also increase islet cAMP content. The binding of various ligands to receptors in the plasmalemma of cells activates adenylate cyclase, which converts ATP to cAMP (34) . cAMP has been established as a "second messenger" in the regulation of various intracellular processes (34) . This begins a cascade of phosphorylation reactions which activate and inactivate enzymes regulating insulin secretion (35) .
Accordingly, insulin secretion in VEsrTD infected and control islets was compared with cAMP generation (Table I) (27) . Glucagon and glucose or glucose (in the presence ofa specific phosphodiesterase inhibitor) elicit lower cAMP levels and insulin response in islets from hamsters infected with VESg virus. This could result from alteration in the adenylate cyclase system, as well as from non-cAMP-dependent mechanisms. The normal cAMP generation in VEsr virus-infected islets induced by aketoisocaproic acid suggests that there may be specificity to this defect. VE virus replicates in hamster pancreas (6) and its proteins are incorporated into the host cell's membrane during budding (37) . Thus, viral proteins could change the activity of adenylate cyclase as well as act on non-cAMP factors involved in the regulation of insulin secretion.
